Quantitative Evaluation of the Economic Impact of Antimicrobial Resistance on the Treatment of Community-Acquired Acute Pyelonephritis in Korea.
Taul CheongJungmo AhnYun Seop KimHyunjoo PaiBongyoung KimPublished in: Infection & chemotherapy (2022)
Patients with community-acquired APN with ESBL-producing Enterobacteriale as the causative pathogen would incur, on average, 27.0% higher medical costs and 22.0% longer hospitalization days than patients detected with non-ESBL-producing pathogens.
Keyphrases
- antimicrobial resistance
- healthcare
- escherichia coli
- mental health
- end stage renal disease
- newly diagnosed
- ejection fraction
- klebsiella pneumoniae
- respiratory failure
- candida albicans
- patient reported outcomes
- multidrug resistant
- acute respiratory distress syndrome
- aortic dissection
- patient reported
- urinary tract infection